Status:
COMPLETED
Regenerative Endodontic Therapy (RET) for the Management of Immature Non-vital Permanent Teeth in Children
Lead Sponsor:
National University Health System, Singapore
Collaborating Sponsors:
National University of Singapore
Health Promotion Board, Singapore
Conditions:
Infected Immature Permanent Teeth
Eligibility:
All Genders
6-16 years
Phase:
PHASE2
Brief Summary
This study evaluates the efficacy of Antibiotic pastes or Calcium hydroxide disinfection on healing of periapical pathology and continued root development of infected non-vital immature permanent teet...
Eligibility Criteria
Inclusion
- Patients aged 6-16 years of age
- Patients who are fit and healthy or with American Society of Anesthesiologists (ASA) 1 or ASA 2 medical conditions
- Patients with cooperation level that would allow treatment under local analgesia, application of rubber dam isolation and taking of intraoral radiographs.
- Patients with permanent premolars that have incomplete root formation with an open apex of greater than 1mm width as observed radiographically and of single root canal morphology (22)
- Patients with single rooted immature permanent premolars having one of the following pulpal and periapical diagnosis:
- a. Pulpal i. Necrotic pulp ii. Symptomatic and inflamed pulp not expected to heal. During attempted Cvek or cervical pulpotomy procedures, if the pulpal bleeding does not stop with direct pressure within 5 minutes, pulpectomy will be carried out and the patient will be recruited for RET procedures.
- b. Periapical i. Symptomatic apical periodontitis (with or without a radiographic apical lesion) ii. Asymptomatic apical periodontitis (with a radiographic apical lesion) iii. Acute apical abscess iv. Chronic apical abscess Teeth will be deemed non-vital if either are non-responsive to sensibility tests (i.e. Electric Pulp test and cold tests), and/or present with signs and symptoms of non-vitality (e.g. swelling and abscess).
Exclusion
- Patients aged \> 16 years of age.
- Patient with known allergies to Ciprofloxacin (or any fluoroquinolones class of antibiotics) or metronidazole antibiotics.
- Patients with medical conditions and/or receiving medications that would affect:
- Their body's ability to heal e.g. Diabetes; or
- Their ability to clot efficiently, e.g. Haemophilia
- Patients with risk of developing infective endocarditis or immune compromised patients.
- Patients with non-vital permanent premolars where root development is already deemed to be completed (i.e. foramen size of 0-1.0mm diameter as determined radiographically).
- Impacted or horizontally tilted teeth.
- Concurrent signs of irreversible pathological root resorption determined radiographically, e.g replacement or internal root resorption, which could otherwise affect the prognosis of the tooth.
- Uncooperative patients, or those unable to cope with treatment under local anaesthesia, rubber dam isolation and taking of intraoral radiographs.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03327844
Start Date
March 1 2017
End Date
July 31 2021
Last Update
October 21 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
School Dental Service, Health Promotion Board
Singapore, Singapore, 168937
2
National University Hospital
Singapore, Singapore